Novel CIS-imidazolines

Details for Australian Patent Application No. 2005243465 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Simonsen, Klaus B.; Haley, Gregory Jay; Vu, Binh Thanh; Webber, Stephen Evan; Fotouhi, Nader

Agent Davies Collison Cave

Pub. Number AU-B-2005243465

PCT Pub. Number WO2005/110996

Priority 60/572,275 18.05.04 US; 60/668,772 06.04.05 US; 60/615,534 01.10.04 US

Filing date 10 May 2005

Wipo publication date 24 November 2005

Acceptance publication date 25 August 2011

International Classifications

C07D 233/22 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 35/00 (2006.01) Antineoplastic agents

C07D 233/26 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/110996 Priority application(s): WO2005/110996

25 August 2011 Application Accepted

  Published as AU-B-2005243465

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243469-Novel enantiomerically pure betaagonists, method for the production and the use thereof in the form of a drug

2005243462-Improved prebiotic